Decreased [3H] YM-09151-2 binding to dopamine D2 receptors in the hypothalamus, brainstem and pancreatic islets of streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 557, Issue 2-3, 2007, Pages 99-105

  Shankar, P N Eswar ^a   Joseph, Anu ^a   Paulose, C S ^a  

^a Centre for Neuroscience   (India)

Author keywords

Diabetes; Dopamine D2 receptor; Streptozotocin

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; EMONAPRIDE; INSULIN; STREPTOZOCIN; TRITIUM; BENZAMIDE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BRAIN STEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINE BRAIN LEVEL; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR AFFINITY; SCATCHARD PLOT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TISSUE PREPARATION; ANIMAL; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM;

ANIMALS; BENZAMIDES; BRAIN STEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE ANTAGONISTS; HYPOTHALAMUS; ISLETS OF LANGERHANS; RATS; RECEPTORS, DOPAMINE D2;

EID: 33846584086     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.018     Document Type: Article

References (56)

1. Ahren. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43 (2000) 393-410
2. Ani Das V., Remya R., and Paulose C.S. Enhanced β adrenergic receptors in the brain pancreas during pancreatic regeneration in weanling rats. Mol. Cell. Biochem. 289 (2006) 11-19
3. Arison R.N., Ciaccio E.I., Glitzer M.S., Cassaro A.V., and Pruss M. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16 (1967) 51-56
4. Asha A., and Paulose C.S. Age related functions in noradrenergic function in the brain stem of streptozotocin diabetic rats. J. Biochem. Mol. Biol. Biophys. 3 (1999) 171-176
5. Azmitia E.C., and Gannon P. Anatomy of the serotonergic system in the primate and sub-primate brain. J. Adv. Neurol. 43 (1986) 407-468
6. 2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 143 (2002) 1270-1279
7. Bereiter D.A., Rohner-Jeanrenaud F., Berthoud H., and Jeanrenaud R. CNS modulation of pancreatic endocrine function: multiple mode of expression. Diabetologia 20 (1981) 417-425
8. Bitar M.S., Koulu M., and Linnoila M. Diabetes induced changes in monoamine concentrations of rat hypothalamic nucleui. Brain Res. 409 (1987) 236-242
9. 2 like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J. Biol. Chem. 280 (2005) 36824-36832
10. Burr I.M., Slonim A.E., and Sharp R. Interaction of acetylcholine and epinephrine on the dynamics of insulin release in vitro. J. Clin. Invest. 58 (1976) 230-239
11. Campfield L.A., and Smith F.J. Modulation of insulin secretion by the autonomic nervous system. Brain Res. Bull. 4 (1980) 103-107
12. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11 (1959) 490-493
13. Casey D.E., Ganzini L., Heintz R.T., and Hoffman W.F. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Arch. Gen. Psychiatry 48 (1991) 259-263
14. i) and the concentration of an inhibitor that causes a 50% inhibition of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
15. Esler M.D., Lambert G.W., Eisenhofer G., Cox H.S., Horne M., Kalff V., Kelly M., and Jennings G.L. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. Life Sci. 49 (1991) 1061-1072
16. Eswar S.P.N., Santhosh K.T., and Paulose C.S. Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro. IUBMB Life 58 (2006) 157-163
17. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., and Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 964 (2003) 107-115
18. Galli A., Carvelli L., Moron J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., and Lin R.Z. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81 (2002) 859-869
19. 3H] dopa in various regions of brain. J. Neurochem. 13 (1966) 655-669
20. Guillod E., Penicaud L., Leloup C., Lorsignol A., and Alquier T. Brain glucose sensing mechanism and glucose homeostasis. Curr. Opin. Clin. Nutr. Metab. Care. 5 (2003) 539-543
21. Hohenegger M., and Rudas. Kidney functions in experimental diabetic ketosis. Diabetologia 17 (1971) 334-338
22. 2A receptors in the cerebral cortex and brainstem of streptozotocin induced diabetic rats. Mol. Cell. Biochem. 199 (1999) 81-85
23. 2A receptor regulation by tryptophan supplementation in streptozotocin diabetic rats. J. Biochem. Mol. Biol. Biophys. 5 (2000) 1-7
24. Jackson J., Padayatti P.S., Paul T., and Paulose C.S. Platelet monoamine changes in diabetic patients and streptozotocin-induced diabetic rats. Curr. Sci. 72 (1997) 137-139
25. Kamei J., Saitoh A., Iwamoto Y., Funada M., Suzuki T., Misawa M., Nagase H., and Kasuya Y. Effects of diabetes on spontaneous locomotor activity in mice. Neurosci. Lett. 178 (1994) 69-72
26. Laokovic Z., Salkovic M., Kuci Z., and Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54 (1990) 143-147
27. Liang Y., Luo S., and Cincotta A.H. Long term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function. Metabolism 48 (1999) 1287-1289
28. Liu Y.Q., Montanya E., and Leahy J.L. Increased islet DNA synthesis and glucose derived lipid and amino acid production in association with beta cell hyperproliferation in normoglycaemic 60% pancreatectomy rats. Diabetologia 44 (2001) 1026-1033
29. Lowry O.H., Roserbrough N.J., Farr A.L., and Randall R.J. Protein measurements and folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
30. Lozovsky D., Saller C.F., and Kopin l.J. Dopamine receptor binding is increased in diabetic rats. Science 214 (1981) 1031-1033
31. 2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis). J. Neurochem. 51 (1988) 934-943
32. McEvoy R.C., and Hegre O.D. Syngeneic transplantation of fetal rat pancreas. II. Effects of insulin treatment on the growth and differentiation of pancreatic implants 15 days after transplantation. Diabetes 27 (1978) 988-995
33. 2c receptor binding in the cerebral cortex and brainstem during pancreatic regeneration in rats. Mol. Cell. Biochem. 272 (2005) 165-170
34. 1A receptor protein in the cerebral cortex and brainstem during pancreatic regeneration in rats. Neurochem. Res. 30 (2005) 25-32
35. 2C receptors during pancreatic regeneration. Life Sci. 78 (2006) 1603-1609
36. 2+ efflux by dopamine in glucose-stimulated pancreatic islets. Gen. Pharmacol. 25 (1994) 909-916
37. Oler, Yang Z.J., Meguid M.M., Chai J.K., and Chen C. Bilateral hypothalamic dopamine infusion in male Zucker rat suppresses feeding due to reduced meal size. Pharmacol. Biochem. Behav. 58 (1997) 31-35
38. Paulose C.S., Dakshinamurti K., Packer S., and Stephens N.L. Sympathetic stimulation and hypertension in pyridoxine deficient adult rat. Hypertension 11 (1988) 387-391
39. Porte D.J., Graber A.L., Kuzuya T., and Williams R.H. The effect of epinephrine on immunoreactive insulin levels in man. J. Clin. Invest. 45 (1966) 228-236
40. Renuka T.R., Ani Das V., and Paulose C.S. Alterations in the Muscarinic M1 and M3 receptor gene expression in the brainstem during pancreatic regeneration and insulin secretion in weanling rats. Life Sci. 75 (2004) 2269-2280
41. Renuka T.R., Savitha B., and Paulose C.S. Muscarinic M1 and M3 receptor binding alterations in pancreatic regeneration of young rats. Endocr. Res. 31 (2005) 259-270
42. Salkovic M., and Lackovic Z. Central nervous system in diabetes. Diabetol. Croat. 16 (1987) 5-17
43. 1 dopamine receptor in alloxan-induced diabetes. Diabetes 41 (1992) 1119-1121
44. Sasaki S., and Bunag R.D. Insulin reverses hypertension and hypothalamic depression in streptozotocin diabetic rats. Hypertension 5 (1983) 34-40
45. Scatchard. The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51 (1949) 660-672
46. Serri O., Reiner G., and Somma M. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Horm. Res. 21 (1985) 95-101
47. Shimomura Y., Shimizu H., Takahashi M., Sato N., Uehara Y., Suwa K., Kobayashi L., Tadokoro S., and Kobayashi S. Changes in ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats. Endocrinology 123 (1988) 2621-2625
48. Simon C., Paulose C.S., and Ram Mishra K. Neuroleptic drug induced dopamine receptor supersensitivity: antagonism by l-Prolyl-l-Leucyl-Glycinamide. Science 214 (1981) 1261-1262
49. Smith P.H., and Davis B.J. Effect of substantia nigra lesions on the volume of A, B, and D cells and the content of insulin and glucagon in the rat pancreas. Diabetologia 28 (1985) 756-762
50. Tassava T.M., Okuda T., and Romsos D.R. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters. Am. J. Physiol. 262 (1992) E338-E343
51. 3H] spiroperidol binding in streptozotocin-diabetic rats. J. Neurochem. 40 (1983) 1456-1459
52. 3H]-YM-09151-2 specific binding. Dev. Brain Res. 106 (1998) 109-117
53. Unnerstall J.R. Computer analysis of binding data. In: Yamamura H., Enna S., and Kuhar M. (Eds). Methods in Neurotransmitter Receptor Analysis (1990), Raven Press 247-255
54. Vallone D., Picetti R., and Borrelli E. Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24 (2000) 125-132
55. Ying L., Wu X., Zhu J., Yan J., and Chung O. Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. J. Physiol. 552 (2003) 571-587
56. Zhang L., Sato T., Meguid M.M., Fetissov S.O., and Chen C. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 281 (2001) R 1907-R 1916